FDA Adverse Event Injury Summary report: N

CERTAS INLINE VLV

MDR report key: 6456375 · Received April 4, 2017

Report

Report Number
1226348-2017-10229
Event Type
Injury
Date Received
April 4, 2017
Date of Event
March 9, 2017
Manufacturer
CODMAN & SHURTLEFF, INC. / MEDOS S.A.
Product Code
JXG
PMA / PMN Number
K112156
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). UPON COMPLETION OF THE INVESTIGATION, IT WAS NOTED THAT THE POSITION OF THE CAM WHEN VALVE WAS RECEIVED WAS AT SETTING 5. THE VALVE WAS VISUALLY INSPECTED: NO DEFECTS WERE NOTED. THE VALVE WAS HYDRATED. THE VALVE WAS TESTED FOR PROGRAMMING. THE VALVE PASSED THE TEST. THE VALVE WAS FLUSHED, THE VALVE PASSED THE TEST NO OCCLUSION WAS NOTED. THE VALVE WAS LEAK TESTED, NO LEAKS WERE NOTED. THE VALVE WAS REFLUX TESTED. THE VALVE PASSED THE TEST. THE VALVE WAS DRIED. THE VALVE WAS THEN PRESSURE TESTED, THE VALVE PASSED THE TEST. REVIEW OF THE HISTORY DEVICE RECORDS FOR THE CERTAS VALVE, PRODUCT CODE 82-8801 WITH LOT CTBB4LR, SHOWED 2 NR AND 1 NC REPORT WHEN RELEASED TO STOCK ON THE 1ST OCTOBER 2015, THE NR¿S AND NC REPORT ISSUES HAD NO LINK TO THIS COMPLAINT. NO ROOT CAUSE COULD BE DETERMINED, AS THE PROBLEM REPORTED BY THE CUSTOMER COULD NOT BE DUPLICATED. BASED ON THE RESULTS OF THIS INVESTIGATION NO FURTHER ACTION IS REQUIRED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME, THIS COMPLAINT IS CLOSED.

Additional Manufacturer Narrative · 1

(B)(4). UPON COMPLETION OF THE INVESTIGATION, A FOLLOW UP REPORT WILL BE FILED.

Description of Event or Problem · 1

THE VALVE PROGRAMMER SHOW A VALUE (EX:2) AND WHEN THE SURGEON MADE THE RADIOLOGICAL TEST TO CONFIRM, IT SHOWS A DIFFERENT VALUE. IT HAPPENS EVERY TIME THE SURGEON MADE THIS CONFIRMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
238521 CERTAS INLINE VLV SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF, INC. / MEDOS S.A. CTBB4L-R

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention